Kyoto University eyes providing gene-edited iPS cells from 2023

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


The CiRA Foundation has already developed iPS cells using blood from donors who have types of immunity that make them less prone to transplant rejections. | REUTERS
https://www.japantimes.co.jp/news/2022/04/17/national/science-health/gene-editing/

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.